Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status.

[1]  C. Christiansen,et al.  The measurement of secretory endometrial protein PP14 in serum from postmenopausal women receiving unopposed estrogen or continuously combined estrogen/progestogen. , 1989, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[2]  R. Hoover,et al.  Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. , 1989, BMJ.

[3]  S. Bell,et al.  Immunohistological localization of human endometrial secretory protein, 'pregnancy-associated endometrial α2-globulin' (α2-PEG), during the menstrual cycle , 1988 .

[4]  U. Stenman,et al.  The post-menopausal uterus: the effect of hormone replacement therapy on the serum levels of secretory endometrial protein PP14/beta-lactoglobulin homologue. , 1987, Human reproduction.

[5]  R. Rao,et al.  Luteal phase concentrations of a progestagen-associated endometrial protein (PEP) in the serum of cycling women with adequate or inadequate endometrium. , 1986, The Journal of clinical endocrinology and metabolism.

[6]  R. Koistinen,et al.  Secretory endometrium synthesizes placental protein 14. , 1986, Endocrinology.

[7]  U. Stenman,et al.  Serum levels of placental protein 14 reflect ovulation in nonconceptional menstrual cycles. , 1986, Fertility and sterility.

[8]  C. Christiansen,et al.  UNCOUPLING OF BONE FORMATION AND RESORPTION BY COMBINED OESTROGEN AND PROGESTAGEN THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS , 1985, The Lancet.

[9]  H. Bohn,et al.  New soluble placental tissue proteins: their isolation, characterization, localization and quantification. , 1982, Placenta. Supplement.

[10]  M. Whitehead,et al.  Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. , 1981, The New England journal of medicine.

[11]  C. Christiansen,et al.  Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females , 1971, European journal of clinical investigation.

[12]  S. Campbell,et al.  Endometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen Therapy 1 , 1979, Journal of the Royal Society of Medicine.

[13]  W. Creasman,et al.  Effects of long-term estrogen replacement therapy. I. Metabolic effects. , 1979, American journal of obstetrics and gynecology.

[14]  R. Lindsay,et al.  LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN EVIDENCE FOR AN INCREASED BONE MASS AFTER DELAYED ONSET OF ŒSTROGEN TREATMENT , 1976, The Lancet.